GAiA seeks to expand access to lifesaving medicines and combat the communicable disease burden that disproportionately harms the world’s most vulnerable populations. We accomplish this by conducting action-oriented research, supporting breakthrough initiatives, facilitating stakeholder dialogue, and providing policy advice to pharmaceutical firms on best practices to increase impact. 

In combining these core tenets of GAiA, we are confident that the urgent need for increased global access to medicines is feasible, practical, and affordable.

Pragmatism | We seek to identify reforms that will have meaningful impact and can be readily implemented.

Interdisciplinarity | We examine the interplay between intellectual property law, medicines regulation, trade, and public health. 

Multi-institutional | Our primary approach is legal and regulatory reform; we are equally interested in collaborations with private firms or NGOs, and governmental and nongovernmental actors. 

Academic neutrality | We enforce institutional credibility and rigorous scholarships in all aspects of our work.